Диссертация (1140011), страница 16
Текст из файла (страница 16)
– 2012. – 66 (5). – P. 794–800.72.Blume-Peytavi, U. Comparison of the efficacy and safety of topicalminoxidil and topical alfatradiol in the treatment of androgeneticalopecia in women / U. Blume-Peytavi [et al.] // J Dtsch Dermatol Ges.– 2007. – 5(5). – P. 391-5.10873.Blume-Peytavi, U. European consensus on the evaluation of womenpresenting with excessive hair growth / U. Blume-Peytavi [et al.] //European Journal of Dermatology. – 2009. – 19(6).
– P. 597–602.74.Blume-Peytavi, U. S1 guideline for diagnostic evaluation inandrogenetic alopecia in men, women and adolescents // U. BlumePeytavi [et al.] // Br J Dermatol. – 2011. – 164 (1). P. 5-15.75.Blumeyer, A. Evidence-based (S3) guideline for the treatment ofandrogenetic alopecia in women and in men / A. Blumeyer [et al.] // JDtsch Dermatol Ges. – 2011 Oct. – 9 Suppl 6. – S1-57.76.Bouharma, P. Garder et retrouver ses cheveux. Les nouveauxtraitements / P. Bouhanna // Springer-Verlag France. – 2000. – 567 p.77.Bruni, V. Hepatotoxicity with low- and ultralow-dose flutamide: asurveillance study on 203 hyperandrogenic young females / V.
Bruni[et al.] // Fertil Steril. – 2012. – 98 (4). – P. 1047–52.78.Cela, E. Prevalence of polycystic ovaries in women with androgenicalopecia / E. Cela [et al.] // Eur J Endocrinol. – 2003. – 149. – P. 43942.79.Chieh, W. Cutaneous Androgen Metabolism: Basic Research andClinical Perspectives / W. Chieh, D. Chen, С. Zouboulis // J.Investigative Dermatology. – 2002. – Vol.
119. – № 5. – P. 992-995.80.Christy, N. A. Spironolactone for hirsutism in polycystic ovarysyndrome / N. A. Christy, A. S. Franks, L. B. Cross // AnnPharmacother. – 2005. – 39 (9). – P. 1517-21.81.Cohen, J. L. Enhancing the growth of natural eyelashes: themechanism of bimatoprost-induced eyelash growth / J. L. Cohen //Dermatol Surg. – 2010. – 36(9). – P. 1361–1371.82.Cotton, S. G.
Factors discriminating men with coronary heart diseasefrom healthy controls / S. G. Cotton [et al.] // Br Heart J. – 1972. – 34.– P. 458–64.10983.Cousen, P, Female pattern hair loss in complete androgen in sensitivitysyndrome / P. Cousen, A. Messenger // Br J Dermatol. – 2010. – 162. –P. 1135-7.84.D’Amico, D. Phototrichogram using videomicroscopy: a usefultechnique in the evaluation of scalp hair / D. D’Amico [et al.] // Eur JDermatol. – 2001.
– 11. – P. 17–20.85.Dawber, R. P. Oral antiandrogen treatment of common baldness inwomen / R. P. Dawber, T. Sonnex, I. Ralfs // Br J Dermatol. – 1982. –107. – 20–21.86.De Villez, R. L. Androgenetic alopecia in the female. Treatment with2% topical minoxidil solution / R. L. de Villez [et al.] // ArchDermatol. – 1994 Mar. – 130 (3). – P. 303–7.87.Ekmekci T. R. Occipital involvement in female pattern hair loss:histopathological evidences / T. R.
Ekmekci, D. Sakiz, A. Koslu // JEur Acad Dermatol Venerol. – 2010. – 24(3). – P. 299–301.88.Ekmekci, T. R. Phototrichogram findings in women with androgeneticalopecia / T. R. Ekmekci, A. Koslu // Skin Res Technol. – 2006. – 12.– P. 309–312.89.Ekmekçi, T. R. The presence of insulin resistance and comparison ofvarious insulin sensitivity indices in women with androgeneticalopecia. / T. R.
Ekmekçi [et al.] // Eur J Dermatol. – 2007. – 17. – P.21–5.90.Ellis, J. A. Male pattern baldness is not associated with establishedcardiovascular risk factors in the general population / J. A. Ellis, M.Stebbing, S. B. Harrap // Clin Sci. – 2001. – 100. – P. 401–4.91.Emer, J. J. Novel treatment of female-pattern androgenetic alopeciawith injected bimatoprost 0,03% solution / J. J. Emer, M.L. Stevenson,O. Markowitz // J Drugs Dermatol. – 2011. – 10(7). – P. 795–798.92.Finer, A.M.
Hair transplantation –indications and current technique /A. M. Finer // Int. J. Trichol. – 2011. – Vol.3. – N 1. – P. S14.11093.Futterweit, W. The prevalence of hyperandrogenism in 109consecutive female patients with diffuse alopecia / W. Futterweit [etal.] // J Am Acad Dermatol. – 1988. – 19. – P. 831–6.94.Gan, D. C. Prevalence of male and female pattern hair loss inMaryborough / D. C.
Gan, R. D. Sinclair // J Investig Dermatol SympProc. – 2005. – 10. – P. 184–9.95.Gassmueller, J. Topical fulvestrant solution has no effect on male andpostmenopausal female androgenetic alopecia: results from tworandomized, proof-of-concept studies / J. Gassmueller, R. Hoffmann,A. Webster // Br J Dermatol. – 2008. – 158 (1). – P. 109–15.96.Georgala, S. Topical estrogen therapy for androgenetic alopecia inmenopausal females / S.
Georgala [et al.] // Dermatology. – 2004. –208 (2). – P. 178–9.97.Guarrera, M. Quantitating hair loss in women: a critical approach / M.Guarrera, M. T. Semino, A. Rebora // Dermatology. – 1997. – 194(1).– P. 12–16.98.Hamblin, M. R. Mechanisms of low level light therapy / M. R.Hamblin, T.
N. Demidova // Biomedical Optics. – 2006.99.Hamilton, J. B. Male Hormone stimulation is prerequisite and anincitant in common baldness / J.B. Hamilton // American journal ofanatomy. – 1942. – Vol. 71. – P. 451–454.100.Hamilton, J. B. Patterned loss of hair in man; types and incidence/ J. B.Hamilton // Annals of the New York Academy of Sciences.
– 1951. –53(3). – P. 708–728.101.Herskovitz, I. Vellus hairs in the frontal scalp in early female pattern hairloss / I. Herskovitz, I.C. de Sousa, A. Tosti // Int J Trichology. – 2013. –Jul. – 5(3). P. 118–20.102.Hillmann, K. Diagnosis of hair disorders/ K. Hillmann, U. Blume-Peytavi //Seminars in Cutaneous Medicine and Surgery.
– 2009. – 28 (1). – P. 33–38.111103.Hirsso, P. Association of insulin resistance-linked diseases and hair loss inelderly men. Finnish population-based study / P. Hirsso [et al.] // Cent EurJ Public Health. – 2006. – 14. – P. 78-81.104.Horenstein, M. G. Follicular streamers (stelae) in scarring and non-scarringalopecia / M. G. Horenstein, J. S. Jacob // J Cutan Pathol. – 2008 Dec. – 35(12). – P. 1115-20.105.Horton, R. Androgen induction of steroid 5a-reductase may be mediatedvia insulin-like growth factor 1 / R. Horton, V.
Pasupuletti, I. Antonipillai //Endocrinology. – 1993. – 133. – P. 447-51.106.Iorizzo, M. Finasteride treatment of female pattern hair loss / M. Iorizzo [etal.] // Arch Dermatol. – 2006. – 142 (3). – P. 298-302.107.Jacobs, J. P. Use of topical minoxidil therapy for androgenetic alopecia inwomen / J. P. Jacobs, C. A. Szpunar, M. L. Warner // Int J Dermatol. –1993 Oct.
– 32(10). – P. 758-62.108.James, I. Expert Panel on Detection, Evaluation, and Treatment of HighBlood Cholesterol in Adults / I. James // JAMA. – 2001. – 285. – P. 2486–97.109.Johnstone, M.A. Prostaglandin-induced hair growth / M. A. Johnstone, D.M. Albert // Surv Ophthalmol. – 2002. – 47(Suppl 1). – S185–S202.110.Kantor, J.
Decreased serum ferritin is associated with alopecia in women /J. Kantor [et al.] // J Invest Dermatol. – 2003 Nov. – 121 (5). – P. 985-8.111.Kaufman, K. D. Androgens and alopecia / K. D. Kaufman // Mol CellEndocrinol. – 2002. –198. – P. 89–95.112.Kim, B. J. Androgenetic alopecia in adolescents: a report of 43 cases / B.
J.Kim [et al.] // J Dermatol. – 2006. – 33. – P. 696–9.113.Kim, W.J. Efficacy of Finasteride 1.25 mg on Female Pattern Hair Loss;Pilot Study / W.J. Kim [et al.] // Ann Dermatol. – 2012 Aug. – 24 (3). – P.370-2.112114.Kohler, C. Effect of finasteride 5 mg (Proscar) on acne and alopecia infemale patients with normal serum levels of free testosterone / C. Kohler[et al.] // Gynecol Endocrinol. – 2007. – 23 (3). – P. 142-5.115.Küster, W. The inheritance of common baldness: two B or not two B? / W.Küster, R. Happle // Journal of the American Academy of Dermatology.
–1984. – 11(5, part 1). – P. 921–926.116.Lacharriere, O. Hair diameter diversity: a clinical sign reflecting the follicleminiaturization / O. Lacharriere [et al.] // Arch Dermatol. – 2001. – 137 (5).– P. 641–6.117.Lachgar, S. Minoxidil upregulates the expression of vascular endothelialgrowth factor in human hair dermal papilla cells / S. Lachgar [et al.] // Br JDermatol.
– 1998 Mar. – 138 (3). – P. 407–11.118.Leavitt, M. Understanding and management of female pattern alopecia / M.Leavitt // Facial Plast Surg. – 2008. – 24 (4). – P. 414–27.119.Lee, S. H. Therapeutic efficacy of autologous platelet-rich plasma andpolydeoxyribonucleotide on female pattern hair loss / S. H. Lee [et al.] //Wound Repair Regen. – 2015 Jan-Feb. – 23 (1). – P. 30–6.120.Leroy, T. Contrast enhanced phototrichogram pinpoints scalp hair changesin androgen sensitive areas of male androgenetic alopecia / T. Leroy, D.Van Neste // Skin Res Technol.
– 2002. – № 8. – P. 106–111.121.Lucky, A.W. A randomized, placebo controlled trial of 5% and 2% topicalminoxidil solutions in the treatment of female pattern hair loss / A. W.Lucky [et al.] // J Am Acad Dermatol. – 2004 Apr. – 50 (4). – P. 541–53.122.Ludwig, E. Classification of the types of androgenetic alopecia (commonbaldness) occurring in the female sex / E. Ludwig // British Journal ofDermatology. – 1977. – 97(3).
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
